Guo Guangchang has "selling medicines" again.

↑ Picture according to IC Photo

On the evening of September 2nd, Fosun Pharmaceutical (600196.SH; 02196.HK) announced that the company's controlling shareholder plan to reduce the company's A shares with a total share capital of 3%.

The Red Star Capital Bureau noticed that behind the Hosting Hosting of Fosun Pharmaceutical's controlling shareholder, Guo Guangchang. If the closing price of Fosun Pharmaceutical on September 2 is calculated at 40.21 yuan/share, the controlling shareholder Shanghai Fosun High Technology (Group) Co., Ltd. (hereinafter referred to as "Fosun High Technology") will cash out about 3.22 billion yuan. It is worth mentioning that, in addition to Fosun Pharmaceutical, Guo Guangchang has reached more than 10 billion through reduction and transfer of related listed companies this year.

On September 4, the Red Star Capital Bureau sent an interview with Fosun Medicine, but did not reply.

Guo Guangchang's hand -down reduction

Or 3.2 billion yuan

Recently, Fosun Pharmaceutical Announcement stated that the controlling shareholder Shanghai Fosun Hi -Tech Plan plans to reduce its holdings by centralized bidding and transaction methods that does not exceed 3%of the company's total share capital. 800.897 million A shares.

Among them, A -shares with a centralized bidding method that does not exceed 1%of Fosun Pharmaceutical's total share capital is planned from September 27, 2022 to March 26, 2023 (including the first two days); A shares with a reduction of 2%of the company's total share capital are planned, and the plan is planned to reduce its holdings from September 8, 2022 to March 7, 2023 (including the first two days).

According to the closing price of 40.21 yuan/share on September 2, Fosun High Technology will cash out about 3.22 billion yuan. As for the reasons for reducing holdings, Fosun Hi -Tech said that it needs its own business plan.

After the completion of this reduction, Fosun High Technology holding Fosun Pharmaceutical's shares will be reduced from 37.82%to 34.82%, plus Fosun High -tech controlling shareholder Fosun International (00656.HK) 0.22%of the shareholding ratio The two companies accounted for about 35.04%of Fosun Pharmaceutical's total share capital. In other words, this reduction will not cause the control of Fosun Pharmaceutical to change.

It is worth noting that Fosun High Technology, as the controlling shareholder of Fosun Pharmaceutical, is behind it is the growing "Fosun" controlled by Guo Guangchang. As of now, Guo Guangchang has 11 in A shares including Fosun International, Nangang International (600282.SH), Yuyuan (600655.SH), Jin Huijiu, Li Li Liquor (600702.SH), Listed companies.

"Fosun" has recently reduced its holdings frequently

Moody's lower rating of it

Not only Fosun Pharmaceutical, this year, Guo Guangchang has frequently reduced its holdings of its shares of its shares and holding listed companies.

On the evening of September 2nd, the Jinhui Wine (603919.SH) announced that the controlling shareholder Yuyuan and its consistent actors Hainan Yuzhu Enterprise Management Co., Ltd. (hereinafter referred to as "Hainan Yuzhu") transferred the gold emblem wine held respectively 5%and 8%shares. After the transfer is completed, the actual controller will be changed from Guo Guangchang, who has been in the two years to Att Group.

In addition, Guo Guangchang also reduced the different shares of Hainan Mining, Tsingtao Beer (600600.SH; Qingdao Beer Co., Ltd.: 00168.HK), Zhongshan Public (000685.SZ), and Taihe Technology (300801.SZ). If the above -mentioned reduction and transfer of Fosun Pharmaceutical and Jin Huijiu shares, Guo Guangchang will cash out over 10 billion yuan.

The frequent cash out of the "Fosun" is related to its own debt pressure.

On August 23 this year, the rating agency Moody's issuance reported the Fosun International's corporate family rating to B1, the rating outlook was negative, and the high -end unsecured debt rating of Fortune Star (BVI) Limited was reduced from BA3 to BA3 to B1, the bond provides unconditional and irrevocable guarantees by Fosun. Moody's outlook for all the above -mentioned rating was adjusted from rating observation to negative.

It is reported that the negative outlook reflects the uncertainty of re -financing, repay the risk of a large amount of debt expired in the next 12 months by selling assets, and the company's continuous challenge to balance its liquidity demand and maintain the quality of investment portfolio. Essence

Regarding Moody's rating adjustment, Fosun International responded that Fosun International's operating situation was stable, thanks to a diversified asset portfolio, abundant book capital, stable relationships with financial institutions, and smooth diversified financing channels. This rating adjustment was adjusted this time It does not affect Fosun's debt capacity.

Red Star News reporter Deng Lingyao

Editor Deng Yiguang Editor Pan Li

- END -